VivoSim Appoints Ragoo Raghunathan as VP of Global Sales to Drive Liver and GI Toxicity Solutions
ByAinvest
Tuesday, Mar 3, 2026 8:06 am ET1min read
VIVS--
VivoSim has appointed Dr. Arumugham (Ragoo) Raghunathan as Vice President of Global Sales to lead commercial expansion and secure strategic partnerships with biopharma companies. Dr. Raghunathan brings extensive experience in drug discovery and advanced in vitro biology, and will focus on delivering VivoSim's liver and GI toxicity solutions for earlier de-risking of drug candidates. He will help customers generate clearer, earlier signals and move forward with the best programs with confidence, maximizing both cost and time efficiency.

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet